The stock decreased 0.89% or $0.01 on July 21, reaching $1.11. About 265,291 shares traded. Cytori Therapeutics Inc (NASDAQ:CYTX) has declined 65.60% since July 22, 2016 and is downtrending. It has underperformed by 82.30% the …
Shares of Cytori Therapeutics (CYTX) traded down 0.022% during mid-day trading on Tuesday, hitting $0.464. The company's stock had a trading volume of 443,297 shares. A hedge fund recently raised its stake in Cytori Therapeutics …
SAN DIEGO, July 25, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) (the “Company”), announced today that the Compensation Committee of the Company's Board of Directors granted non-qualified stock
Cytori Therapeutics (NASDAQ:CYTX) reported first quarter earnings after market close today, that beat street view. On a GAAP basis, CYTX reported net loss of $ 7.5 million or 33 cents per share, compared with loss of $ 5.3 million or 41 …
CYTX) has received the dreaded one-star ranking. With that in mind, let's take a closer look at Cytori's business and see what CAPS investors are saying about the stock right now. Sources: Capital IQ (a division of Standard & Poor's) and …
The stock is trading below its 50-day and 200-day moving averages of $0.48 and $1.32, respectively. Furthermore, …
The complimentary report on CYTX can be downloaded at: San Diego, California headquartered La Jolla Pharmaceutical …